» Articles » PMID: 39719685

Multiple Sclerosis: Glial Cell Diversity in Time and Space

Overview
Journal Glia
Specialty Neurology
Date 2024 Dec 25
PMID 39719685
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is the most prevalent human inflammatory disease of the central nervous system with demyelination and glial scar formation as pathological hallmarks. Glial cells are key drivers of lesion progression in MS with roles in both tissue damage and repair depending on the surrounding microenvironment and the functional state of the individual glial subtype. In this review, we describe recent developments in the context of glial cell diversity in MS summarizing key findings with respect to pathological and maladaptive functions related to disease-associated glial subtypes. A particular focus is on the spatial and temporal dynamics of glial cells including subtypes of microglia, oligodendrocytes, and astrocytes. We contextualize recent high-dimensional findings suggesting that glial cells dynamically change with respect to epigenomic, transcriptomic, and metabolic features across the inflamed rim and during the progression of MS lesions. In summary, detailed knowledge of spatially restricted glial subtype functions is critical for a better understanding of MS pathology and its pathogenesis as well as the development of novel MS therapies targeting specific glial cell types.

References
1.
Howell O, Rundle J, Garg A, Komada M, Brophy P, Reynolds R . Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol. 2010; 69(10):1017-1033. PMC: 4335193. DOI: 10.1097/NEN.0b013e3181f3a5b1. View

2.
Rothhammer V, Mascanfroni I, Bunse L, Takenaka M, Kenison J, Mayo L . Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016; 22(6):586-97. PMC: 4899206. DOI: 10.1038/nm.4106. View

3.
Coman I, Aigrot M, Seilhean D, Reynolds R, Girault J, Zalc B . Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain. 2006; 129(Pt 12):3186-95. DOI: 10.1093/brain/awl144. View

4.
Li Q, Cheng Z, Zhou L, Darmanis S, Neff N, Okamoto J . Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019; 101(2):207-223.e10. PMC: 6336504. DOI: 10.1016/j.neuron.2018.12.006. View

5.
Siletti K, Hodge R, Mossi Albiach A, Lee K, Ding S, Hu L . Transcriptomic diversity of cell types across the adult human brain. Science. 2023; 382(6667):eadd7046. DOI: 10.1126/science.add7046. View